This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


trusted source


Personal psychedelic use may be common among psychedelic therapists

Personal psychedelic use may be common among psychedelic therapists
Participants' belief in psilocybin therapy efficacy compared with placebo. Credit: Psychedelic Medicine (2023). DOI: 10.1089/psymed.2022.0004

Whether personal use of psychedelics is appropriate among psychedelic therapists, a new study finds that it may be common. The study is published in Psychedelic Medicine.

Experiential learning is common in psychotherapy. Psychedelic therapy is a practice that uses psychedelics such as psilocybin as an adjunct to psychotherapy. Some contend that having personal experience with psychedelics is essential to understanding the effects of these substances and being an effective psychedelic therapist, although there are no data that support this contention, psychedelics remain Schedule I controlled substances, and use outside of approved research settings is illegal in the United States, United Kingdom, and elsewhere

Jacob Aday, Ph.D., from the University of California, San Francisco, and co-authors surveyed psychedelic therapists involved in a trial of psilocybin to treat major depressive disorder. The vast majority of the respondents reported using psychedelic compounds.

More information: Jacob S. Aday et al, Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice, Psychedelic Medicine (2023). DOI: 10.1089/psymed.2022.0004

Citation: Personal psychedelic use may be common among psychedelic therapists (2023, February 27) retrieved 17 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Use of psychedelics to treat PTSD, OCD, depression and chronic pain—a researcher discusses recent trials, possible risks


Feedback to editors